although, the overall estimates of treatment efficacy (active treatment-placebo) based on linear mixed models do not show a significant effect, time-specific estimates of treatment efficacy indicate significant reductions for ki (p = 0.02) and vas (p = 0.03) and a marginally significant reduction (p = 0.06) for mrs after 16 weeks.